New Owner
Mylan Technologies - Abbott Laboratories - Non-U.S. Developed Markets Specialty and Branded Generics Business
Mylan Technologies acquires Abbott Laboratories - Non-U.S. Developed Markets Specialty and Branded Generics Business
Announced: July 14, 2014
Type: Acquisition
Disposition: Subsidiary
Status: Complete
Amount: $ 5,300,000,000
Mylan Technologies Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| May 13, 2016 |
|
$ 950,000,000 |
| Feb 10, 2016 |
|
$ 7,200,000,000 |
| Apr 08, 2015 |
|
$ 28,900,000,000 |
| Dec 06, 2013 |
|
$ 1,750,000,000 |
| Nov 09, 2011 |
|
Undisclosed amount |
